Reducing depressive symptomatology with a smartphone app: study protocol for a randomized, placebo-controlled trial

Area of Science:

• Digital mental health
• Clinical psychology
• Mobile health interventions

Background:

• Depression is a leading global health burden with limited treatment access.
• Mobile applications offer a scalable solution for mental health care.
• Previous studies on depression apps show promise but lack rigorous methodology.

Purpose of the Study:

• To test a novel mobile app grounded in cognitive behavioral therapy (CBT) for depression.
• To determine the app's clinical utility in reducing moderate depressive symptoms compared to an active placebo.
• To assess the app's impact on emotional wellbeing and depressogenic cognitions.

Main Methods:

• Randomized controlled trial with three arms: active intervention, placebo, and delayed intervention.
• Inclusion of Romanian-speaking adults with moderate depressive symptoms (PHQ-9 scores 9-16).
• A 6-week intervention period with weekly therapist check-ins, followed by primary outcome assessment.

Main Results:

• The study protocol is the first RCT to include an active placebo for smartphone-based depression interventions.
• This research aims to provide robust evidence on the efficacy of digital CBT for depression.
• Findings will contribute to understanding the 'digital placebo effect' in mental health apps.

Conclusions:

• This study will add significant evidence to the field of digital therapeutics for depression.
• Results are expected to inform the development and implementation of effective mobile mental health solutions.
• The rigorous design, including an active placebo, will enhance the validity of the findings.